ARCHIVES

In Brief: FDA Stops Imports Of Counterfeit Adriamychin; Rosenburg: NIH Pay 25-33% That Of Academia

This article is from The Cancer Letter archive.

Vol. 14 No. 17 | April 22, 1988

Download PDF Visit The Full Archive

Related Articles

Routine Sampling Of Breast Duct Cells For Detection Of Cancer Precursors Possible With Ductal Lavage System

July 28, 2000

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

June 5, 1987

Analysis Reveals Patient Subset With Lower PFS in Phase III Trial

December 30, 2011

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986

US Oncology To Participate In Firm’s Ovarian Cancer Trial.

January 26, 2001